Metformin and Pancreatitis chronic - a phase IV clinical study of FDA data
Pancreatitis chronic is found among people who take Metformin, especially for people who are male, 60+ old, have been taking the drug for 2 - 5 years.
The phase IV clinical study analyzes which people take Metformin and have Pancreatitis chronic. It is created by eHealthMe based on reports of 395,495 people who have side effects when taking Metformin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
395,495 people reported to have side effects when taking Metformin.
Among them, 267 people (0.07%) have Pancreatitis chronic.
What is Metformin?
Metformin has active ingredients of metformin hydrochloride. It is often used in diabetes. eHealthMe is studying from 373,350 Metformin users for its effectiveness, alternative drugs and more.
What is Pancreatitis chronic?
Pancreatitis chronic (chronic inflammation of pancreas) is found to be associated with 875 drugs and 439 conditions by eHealthMe.
Number of Metformin and Pancreatitis chronic reports submitted per year:
Time on Metformin when people have Pancreatitis chronic *:
Gender of people who have Pancreatitis chronic when taking Metformin*:
Age of people who have Pancreatitis chronic when taking Metformin *:
Common drugs people take besides Metformin *:
Common side effects people have besides Pancreatitis chronic *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Metformin and have Pancreatitis chronic?Check whether Pancreatitis chronic is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- T.Audi Yanto, I.Huang, F.Nathania Kosasih, NP Hardjo Lugito, "Nightmare and Abnormal Dreams: Rare Side Effects of Metformin?", Case Reports in Endocrinology, 2018 Jan .
- Al-Hamdy RA, "Assessment of electrolytes and HbA1c in type 2 diabetic patients using metformin and evaluation of guidelines obedience regarding renal impairment", J.Thi-Qar Sci., 2015 Jan .
- Wiwanitkit S, Wiwanitkit V, "Metformin and sleep disorders", Indian journal of endocrinology and metabolism, 2012 Jan .
Alternative drugs to, pros and cons of Metformin:
- Metformin (373,350 reports)
Pancreatitis chronic treatments and more:
- Pancreatitis chronic (3,690 reports)
COVID vaccines that are related to Pancreatitis chronic:
- Pancreatitis chronic in Moderna COVID Vaccine
- Pancreatitis chronic in Pfizer BioNTech Covid Vaccine
- Pancreatitis chronic in Johnson and Johnson Covid Vaccine
How severe was Pancreatitis chronic and when was it recovered:
Expand to all the drugs that have ingredients of metformin hydrochloride:
Common drugs associated with Pancreatitis chronic:
All the drugs that are associated with Pancreatitis chronic:
- Pancreatitis chronic (875 drugs)
Common conditions associated with Pancreatitis chronic:
All the conditions that are associated with Pancreatitis chronic:
- Pancreatitis chronic (439 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on metformin hydrochloride (the active ingredients of Metformin) and Metformin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Vimizim and Diabetes - 4 seconds ago
- Tylenol and Subacute Endocarditis - 6 seconds ago
- Entresto and Pyonephrosis - 14 seconds ago
- Sulfamethoxazole And Trimethoprim and Enlarged Heart - 19 seconds ago
- Tasigna and Amoxicillin drug interaction - 20 seconds ago